Another milestone for Dexcom. They just have too much fighter power. Wondering if I should bail my current project and jump over at Insulet with their partnership with Dexcom on the AI pancreas.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.